TRPV4 Mechanotransduction in Fibrosis

Fibrosis is an irreversible, debilitating condition marked by the excessive production of extracellular matrix and tissue scarring that eventually results in organ failure and disease. Differentiation of fibroblasts to hypersecretory myofibroblasts is the key event in fibrosis. Although both soluble...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ravi K. Adapala, Venkatesh Katari, Lakshminarayan Reddy Teegala, Sathwika Thodeti, Sailaja Paruchuri, Charles K. Thodeti
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/9a9e435468a54c488590fc3d94a0e42b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9a9e435468a54c488590fc3d94a0e42b
record_format dspace
spelling oai:doaj.org-article:9a9e435468a54c488590fc3d94a0e42b2021-11-25T17:10:57ZTRPV4 Mechanotransduction in Fibrosis10.3390/cells101130532073-4409https://doaj.org/article/9a9e435468a54c488590fc3d94a0e42b2021-11-01T00:00:00Zhttps://www.mdpi.com/2073-4409/10/11/3053https://doaj.org/toc/2073-4409Fibrosis is an irreversible, debilitating condition marked by the excessive production of extracellular matrix and tissue scarring that eventually results in organ failure and disease. Differentiation of fibroblasts to hypersecretory myofibroblasts is the key event in fibrosis. Although both soluble and mechanical factors are implicated in fibroblast differentiation, much of the focus is on TGF-β signaling, but to date, there are no specific drugs available for the treatment of fibrosis. In this review, we describe the role for TRPV4 mechanotransduction in cardiac and lung fibrosis, and we propose TRPV4 as an alternative therapeutic target for fibrosis.Ravi K. AdapalaVenkatesh KatariLakshminarayan Reddy TeegalaSathwika ThodetiSailaja ParuchuriCharles K. ThodetiMDPI AGarticlecalciumextracellular matrixfibroblastfibrosismechanotransductionmyofibroblastBiology (General)QH301-705.5ENCells, Vol 10, Iss 3053, p 3053 (2021)
institution DOAJ
collection DOAJ
language EN
topic calcium
extracellular matrix
fibroblast
fibrosis
mechanotransduction
myofibroblast
Biology (General)
QH301-705.5
spellingShingle calcium
extracellular matrix
fibroblast
fibrosis
mechanotransduction
myofibroblast
Biology (General)
QH301-705.5
Ravi K. Adapala
Venkatesh Katari
Lakshminarayan Reddy Teegala
Sathwika Thodeti
Sailaja Paruchuri
Charles K. Thodeti
TRPV4 Mechanotransduction in Fibrosis
description Fibrosis is an irreversible, debilitating condition marked by the excessive production of extracellular matrix and tissue scarring that eventually results in organ failure and disease. Differentiation of fibroblasts to hypersecretory myofibroblasts is the key event in fibrosis. Although both soluble and mechanical factors are implicated in fibroblast differentiation, much of the focus is on TGF-β signaling, but to date, there are no specific drugs available for the treatment of fibrosis. In this review, we describe the role for TRPV4 mechanotransduction in cardiac and lung fibrosis, and we propose TRPV4 as an alternative therapeutic target for fibrosis.
format article
author Ravi K. Adapala
Venkatesh Katari
Lakshminarayan Reddy Teegala
Sathwika Thodeti
Sailaja Paruchuri
Charles K. Thodeti
author_facet Ravi K. Adapala
Venkatesh Katari
Lakshminarayan Reddy Teegala
Sathwika Thodeti
Sailaja Paruchuri
Charles K. Thodeti
author_sort Ravi K. Adapala
title TRPV4 Mechanotransduction in Fibrosis
title_short TRPV4 Mechanotransduction in Fibrosis
title_full TRPV4 Mechanotransduction in Fibrosis
title_fullStr TRPV4 Mechanotransduction in Fibrosis
title_full_unstemmed TRPV4 Mechanotransduction in Fibrosis
title_sort trpv4 mechanotransduction in fibrosis
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/9a9e435468a54c488590fc3d94a0e42b
work_keys_str_mv AT ravikadapala trpv4mechanotransductioninfibrosis
AT venkateshkatari trpv4mechanotransductioninfibrosis
AT lakshminarayanreddyteegala trpv4mechanotransductioninfibrosis
AT sathwikathodeti trpv4mechanotransductioninfibrosis
AT sailajaparuchuri trpv4mechanotransductioninfibrosis
AT charleskthodeti trpv4mechanotransductioninfibrosis
_version_ 1718412668032778240